Werner Leber
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Werner Leber has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Chris Griffiths
Centre for Primary Care and Public Health, Queen Mary University of London, London, UK
2 shared publications- Jane Anderson
Homerton University Hospital London UK
2 shared publications A Martineau
Queen Mary, University of London, London, UK
1 shared publicationAc Santos
London School of Hygiene and Tropical Medicine, London, UK
1 shared publicationC Griffiths
Queen Mary, University of London, London, UK
1 shared publication- D Millett
Homerton University Hospital NHS Foundation Trust, London, UK
1 shared publication
Latest Publications
- 20 October 2015
- Published by BMJ in Sexually Transmitted Infections
- Vol. 91 (7) , 464-465
HIV testing in Europe: how can primary care contribute?
Undiagnosed HIV infection is a major challenge in the quest to achieve an AIDS-free world. Undetected HIV and late diagnosis are associated with ill health, increased risk of death from HIV/AIDS and onward viral transmission, constituting a substantial burden to public health budgets worldwide. Roughly half of the 2.2 million people with HIV in Europe are undiagnosed.1 These figures are mirrored in the UK and the USA, where almost one-quarter of >100 000 and one-sixth of 1.1 million people with HIV remain undiagnosed, respectively.2 ,3 Unacceptably high proportions (up to 53%) of patients are diagnosed late (CD4 cell count <350 cells/μL).1 Expansion of HIV testing is therefore key to improving HIV outcomes. Early diagnosis followed by immediate antiretroviral treatment reduces HIV-related illness and death. Recent data from both the Strategic Timing of AntiRetroviral Treatment and TEMPRANO ANRS 12136 trials have unambiguously shown that these benefits also extend to patients diagnosed at CD4 of ≥500/μL.4 ,5 Timely diagnosis and treatment have additionally been shown to reduce onward transmission at both individual and population levels, indicating that treatment and prevention are inextricably linked,6 and routine HIV testing is considered cost-effective even when combining one-time HIV screening for the whole population with more frequent testing in subpopulations at risk.7 Given these facts, why …
- 20 October 2015
- Published by BMJ in Sexually Transmitted Infections
- Vol. 91 (7) , 464-465
HIV testing in Europe: how can primary care contribute?
Undiagnosed HIV infection is a major challenge in the quest to achieve an AIDS-free world. Undetected HIV and late diagnosis are associated with ill health, increased risk of death from HIV/AIDS and onward viral transmission, constituting a substantial burden to public health budgets worldwide. Roughly half of the 2.2 million people with HIV in Europe are undiagnosed.1 These figures are mirrored in the UK and the USA, where almost one-quarter of >100 000 and one-sixth of 1.1 million people with HIV remain undiagnosed, respectively.2 ,3 Unacceptably high proportions (up to 53%) of patients are diagnosed late (CD4 cell count <350 cells/μL).1 Expansion of HIV testing is therefore key to improving HIV outcomes. Early diagnosis followed by immediate antiretroviral treatment reduces HIV-related illness and death. Recent data from both the Strategic Timing of AntiRetroviral Treatment and TEMPRANO ANRS 12136 trials have unambiguously shown that these benefits also extend to patients diagnosed at CD4 of ≥500/μL.4 ,5 Timely diagnosis and treatment have additionally been shown to reduce onward transmission at both individual and population levels, indicating that treatment and prevention are inextricably linked,6 and routine HIV testing is considered cost-effective even when combining one-time HIV screening for the whole population with more frequent testing in subpopulations at risk.7 Given these facts, why …
- Open Access
- 27 May 2014
- Published by Royal College of General Practitioners in British Journal of General Practice
- Vol. 64 (623) , 276.1-276
Editor’s choice
We were interested to read the article by Glew and colleagues on opt-out testing for HIV.1 In 2009, our team demonstrated the feasibility and acceptability of opt-out point-of-care (POC) HIV testing in general …
- 27 May 2014
- Published by Royal College of General Practitioners in British Journal of General Practice
- Vol. 64 (623) , 276.1-276
Open AccessEditor’s choice
We were interested to read the article by Glew and colleagues on opt-out testing for HIV.1 In 2009, our team demonstrated the feasibility and acceptability of opt-out point-of-care (POC) HIV testing in general …
- 1 November 2013
- Published by Elsevier in The Lancet
- Vol. 382, S7
Point-of-care HIV testing in primary care and early detection of HIV (RHIVA2): a cluster randomised controlled trial
- 1 November 2013
- Published by Elsevier in The Lancet
- Vol. 382, S7
Point-of-care HIV testing in primary care and early detection of HIV (RHIVA2): a cluster randomised controlled trial